Skip to content

>

⌘K

ScreenerSCR·CompareCMP·GraphG·ExpectationsEXPPortfolioPORT·BuilderPRTMManagersMGR·Best IdeasIDEA·CongressCG·ShortsSHORTS·EventsEVX·CalendarCAL·AnalystsRATEWatchlistWL·AlertsALRT·WorkspaceWS

Special Topics ▾

AI Infrastructure Defense Quantum

Screener Portfolio Managers Watchlist

Research & analytics software — not investment advice, and not a broker-dealer or adviser

Pricing Methodology Guide Terms Privacy Refund Disclaimer Data sources Notices Support

TSHA · Taysha Gene Therapies, Inc. — SPZCO

TSHA US Equity

Taysha Gene Therapies, Inc.

Nasdaq+ Compare Tear sheet →

Health Care · Biological Products, (No Diagnostic Substances) · CIK 1806310 · FYE 1231

$5.61

+0.15 (+2.75%)

USD · as of 2026-07-29 · marketstack

Switch Ticker

DESOverview GPChartFAFinancials FSStrengthFVFair Value RVRelative ValueEARNEarnings ANRRatings EVTSEventsOWNOwnership SIShort InterestRSKRisk

Related →Rank the universe by priced-in expectations AI Study — the value-chain map Relative value vs sector FV methodology Base-rate methodology Greenwald-ladder methodology (display-only)